Roy A. Whitfield
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Sep 23: stock award (2,000 NKTR shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Roy A. Whitfield reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Roy A. Whitfield's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for Roy A. Whitfield
Use this page
How to cite
Breakaway, Roy A. Whitfield: Director at Nektar Therapeutics (NKTR), Sep 23, 2026, getbreakaway.com/insiders/roy-a-whitfield
Journalists: email support@getbreakaway.com for the data behind this page.